A Multi-Center Open Label Single Arm Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Phase of Trial: Phase II
Latest Information Update: 26 Jul 2018
At a glance
- Drugs Carboplatin (Primary) ; Palbociclib (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 21 Sep 2017 Status changed from not yet recruiting to recruiting.
- 06 Sep 2017 Planned initiation date changed from 1 Sep 2017 to 1 Nov 2017.
- 03 Aug 2017 Planned initiation date changed from 3 Jul 2017 to 1 Sep 2017.